250 related articles for article (PubMed ID: 18475180)
1. Correction of hyperoxaluria by liver repopulation with hepatocytes in a mouse model of primary hyperoxaluria type-1.
Jiang J; Salido EC; Guha C; Wang X; Moitra R; Liu L; Roy-Chowdhury J; Roy-Chowdhury N
Transplantation; 2008 May; 85(9):1253-60. PubMed ID: 18475180
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic correction of a mouse model for primary hyperoxaluria with adeno-associated virus gene transfer.
Salido E; Rodriguez-Pena M; Santana A; Beattie SG; Petry H; Torres A
Mol Ther; 2011 May; 19(5):870-5. PubMed ID: 21119625
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of hepatocyte transplantation-based therapies for primary hyperoxalurias.
Guha C; Yamanouchi K; Jiang J; Wang X; Roy Chowdhury N; Santana A; Shapiro LJ; Salido E; Roy-Chowdhury J
Am J Nephrol; 2005; 25(2):161-70. PubMed ID: 15849463
[TBL] [Abstract][Full Text] [Related]
4. Systemic Alanine Glyoxylate Aminotransferase mRNA Improves Glyoxylate Metabolism in a Mouse Model of Primary Hyperoxaluria Type 1.
Kukreja A; Lasaro M; Cobaugh C; Forbes C; Tang JP; Gao X; Martin-Higueras C; Pey AL; Salido E; Sobolov S; Subramanian RR
Nucleic Acid Ther; 2019 Apr; 29(2):104-113. PubMed ID: 30676254
[TBL] [Abstract][Full Text] [Related]
5. Generation of a Primary Hyperoxaluria Type 1 Disease Model Via CRISPR/Cas9 System in Rats.
Zheng R; Fang X; He L; Shao Y; Guo N; Wang L; Liu M; Li D; Geng H
Curr Mol Med; 2018; 18(7):436-447. PubMed ID: 30539697
[TBL] [Abstract][Full Text] [Related]
6. Combined liver-kidney transplantation in primary hyperoxaluria type 1.
Cochat P; Gaulier JM; Koch Nogueira PC; Feber J; Jamieson NV; Rolland MO; Divry P; Bozon D; Dubourg L
Eur J Pediatr; 1999 Dec; 158 Suppl 2():S75-80. PubMed ID: 10603104
[TBL] [Abstract][Full Text] [Related]
7. Generation and characterization of a novel rat model of primary hyperoxaluria type 1 with a nonsense mutation in alanine-glyoxylate aminotransferase gene.
Li Y; Zheng R; Xu G; Huang Y; Li Y; Li D; Geng H
Am J Physiol Renal Physiol; 2021 Mar; 320(3):F475-F484. PubMed ID: 33491567
[TBL] [Abstract][Full Text] [Related]
8. Generation of induced pluripotent stem cells-derived hepatocyte-like cells for ex vivo gene therapy of primary hyperoxaluria type 1.
Estève J; Blouin JM; Lalanne M; Azzi-Martin L; Dubus P; Bidet A; Harambat J; Llanas B; Moranvillier I; Bedel A; Moreau-Gaudry F; Richard E
Stem Cell Res; 2019 Jul; 38():101467. PubMed ID: 31151050
[TBL] [Abstract][Full Text] [Related]
9. Targeted gene therapy in human-induced pluripotent stem cells from a patient with primary hyperoxaluria type 1 using CRISPR/Cas9 technology.
Estève J; Blouin JM; Lalanne M; Azzi-Martin L; Dubus P; Bidet A; Harambat J; Llanas B; Moranvillier I; Bedel A; Moreau-Gaudry F; Richard E
Biochem Biophys Res Commun; 2019 Oct; 517(4):677-683. PubMed ID: 31402115
[TBL] [Abstract][Full Text] [Related]
10. Human MiR-4660 regulates the expression of alanine-glyoxylate aminotransferase and may be a biomarker for idiopathic oxalosis.
Tu X; Zhao Y; Li Q; Yu X; Yang Y; Shi S; Ding Z; Miao Y; Zou Z; Wang X; Jiang J; Du D
Clin Exp Nephrol; 2019 Jul; 23(7):890-897. PubMed ID: 30852714
[TBL] [Abstract][Full Text] [Related]
11. Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter.
Hatch M; Gjymishka A; Salido EC; Allison MJ; Freel RW
Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G461-9. PubMed ID: 21163900
[TBL] [Abstract][Full Text] [Related]
12. Alanine-glyoxylate aminotransferase-deficient mice, a model for primary hyperoxaluria that responds to adenoviral gene transfer.
Salido EC; Li XM; Lu Y; Wang X; Santana A; Roy-Chowdhury N; Torres A; Shapiro LJ; Roy-Chowdhury J
Proc Natl Acad Sci U S A; 2006 Nov; 103(48):18249-54. PubMed ID: 17110443
[TBL] [Abstract][Full Text] [Related]
13. [From gene to disease; primary hyperoxaluria type I caused by mutations in the AGXT gene].
van Woerden CS; Groothof JW; Wanders RJ; Waterham HR; Wijburg FR
Ned Tijdschr Geneeskd; 2006 Jul; 150(30):1669-72. PubMed ID: 16922352
[TBL] [Abstract][Full Text] [Related]
14. In vivo base editing rescues primary hyperoxaluria type 1 in rats.
Chen Z; Zhang D; Zheng R; Yang L; Huo Y; Zhang D; Fang X; Li Y; Xu G; Li D; Geng H
Kidney Int; 2024 Mar; 105(3):496-507. PubMed ID: 38142039
[TBL] [Abstract][Full Text] [Related]
15. Identification of compound heterozygous patients with primary hyperoxaluria type 1: clinical evaluations and in silico investigations.
Kanoun H; Jarraya F; Maalej B; Lahiani A; Mahfoudh H; Makni F; Hachicha J; Fakhfakh F
BMC Nephrol; 2017 Oct; 18(1):303. PubMed ID: 28969594
[TBL] [Abstract][Full Text] [Related]
16. Helper-dependent adenoviral vectors for liver-directed gene therapy of primary hyperoxaluria type 1.
Castello R; Borzone R; D'Aria S; Annunziata P; Piccolo P; Brunetti-Pierri N
Gene Ther; 2016 Feb; 23(2):129-34. PubMed ID: 26609667
[TBL] [Abstract][Full Text] [Related]
17. Further studies on the activity and subcellular distribution of alanine:glyoxylate aminotransferase in the livers of patients with primary hyperoxaluria type 1.
Danpure CJ; Jennings PR
Clin Sci (Lond); 1988 Sep; 75(3):315-22. PubMed ID: 3416563
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of the AGXT gene in patients suspected with hyperoxaluria type 1 and three novel mutations from Turkey.
Isiyel E; Ezgu SA; Caliskan S; Akman S; Akil I; Tabel Y; Akinci N; Ozdogan EB; Ozel A; Eroglu FK; Ezgu FS
Mol Genet Metab; 2016 Dec; 119(4):311-316. PubMed ID: 27915025
[TBL] [Abstract][Full Text] [Related]
19. [Primary hyperoxaluria: A review].
Bouzidi H; Majdoub A; Daudon M; Najjar MF
Nephrol Ther; 2016 Nov; 12(6):431-436. PubMed ID: 27372182
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
